A comprehensive view of AbbVie Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AbbVie Inc. Champions Comprehensive Care and Diversity, Enhancing Autoimmune Standards and Cancer Research in Industry-Leading Initiatives
Published: April 24, 2024 by Industry Intelligence Inc.
AbbVie Inc. Spearheads AML Care Transformation and Advocacy, Enhancing Patient and HCP Support on a Global Scale
Published: April 22, 2024 by Industry Intelligence Inc.
AbbVie Inc. Spearheads Industry Advancements in IBD Management, AML Treatment, and Liver Cancer Prevention
Published: April 20, 2024 by Industry Intelligence Inc.
Healthcare professionals rank AbbVie as top player in immunology, despite competition from Pfizer and J&J, according to ZoomRx analysis; AbbVie scored highest in innovation and patient centricity, while Pfizer and J&J ranked second and third respectively
Published: April 19, 2024 by FiercePharma
AbbVie Inc. Advances Biomedical Research with Longevity Gene Studies and Breakthrough Phase 3 Results in Immunology
Published: April 19, 2024 by Industry Intelligence Inc.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count